Fondazione G.B.Bietti Per Lo Studio E La Ricerca In Oftalmologia

At Fondazione G.B.Bietti Per Lo Studio E La Ricerca In Oftalmologia in Rome, the clinical trial portfolio centers on ophthalmology, with a strong focus on treating and understanding eye diseases that affect vision and retinal health. The research includes studies aimed at improving treatment effectiveness, testing new therapies, and supporting better long-term control of chronic eye conditions.

• Age-related macular degeneration and geographic atrophy
• Diabetic macular edema and other retinal swelling disorders
• Glaucoma and ocular hypertension
• Uveitis, corneal healing, and vision preservation

The site is especially active in trials evaluating new approaches for retinal disease, including therapies designed to slow vision loss, improve visual acuity, and address unmet needs in both degenerative and inflammatory eye disorders.

This research area focuses on major causes of central vision loss, especially neovascular age-related macular degeneration, geographic atrophy, polypoidal choroidal vasculopathy, and choroidal neovascularization secondary to pathologic myopia. The trials are designed to assess new treatments and compare their ability to protect vision and reduce disease progression.

• Testing therapies for wet AMD and related retinal vascular disease
• Evaluating treatments for geographic atrophy linked to dry AMD
• Studying options for myopic choroidal neovascularization
• Assessing treatment benefit in polypoidal choroidal vasculopathy

Several studies at this site examine whether new medicines can improve visual outcomes or slow structural damage in the retina, making this a key area of innovation in macular disease.

Another important focus is diabetic macular edema, a vision-threatening complication of diabetes that can cause retinal fluid buildup and blurred sight. The trials in this field are looking at therapies that may improve visual function and reduce retinal swelling more effectively.

• Diabetic macular edema treatment evaluation
• Comparing new eye drop and injectable options for retinal disease
• Measuring improvement in best-corrected visual acuity
• Supporting better disease control in diabetic eye disease

This work reflects a broader effort to refine treatment for retinal vascular conditions, with the goal of preserving sight and improving day-to-day visual performance in patients with diabetes.

The site also supports clinical research in glaucoma and ocular hypertension, two related conditions that can damage the optic nerve and lead to permanent vision loss if not managed well. These studies are mainly focused on evaluating the safety, tolerability, and effectiveness of new pressure-lowering eye treatments.

• Chronic open-angle glaucoma
• Ocular hypertension
• Comparing new and established eye pressure therapies
• Aiming to improve long-term protection of the optic nerve

By exploring better treatment options for pressure control, the research at Fondazione G.B.Bietti Per Lo Studio E La Ricerca In Oftalmologia contributes to earlier intervention and more durable management of these chronic eye disorders.

Research in this area covers non-infectious uveitis and persistent corneal epithelial defect, both of which can significantly affect comfort, clarity of vision, and overall eye health. The trials are intended to test new anti-inflammatory and healing-focused treatments.

• Intermediate uveitis, posterior uveitis, and panuveitis
• Persistent corneal epithelial defect
• Evaluating therapies that reduce inflammation and support healing
• Improving outcomes in difficult-to-treat ocular surface disease

This field highlights the site’s broader interest in both inflammatory eye disease and tissue repair, with the aim of helping patients recover function and reduce ongoing damage.